Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

By the Numbers: Covid-19 Edition

A collection of facts and figures surrounding the COVID-19 pandemic
Spring/Summer 2020

By the Numbers

A collection of workers’ compensation facts and figures
Winter 2019/2020

State of the States

A roundup of regulatory activity around the country
Winter 2019/2020

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Three More States Introduce Psychedelics Bills, While FDA Sets MDMA Decision Date

Connecticut, Missouri, and New Hampshire join 10 other states considering psychedelics bills.
Mar 2024

Medical Issues Panel at IAIABC Forum & The Fear of Reinjury in Workers’ Comp

Amanda Waltemath, Director of Clinical Services joins a panel discussion on April 10th, and Tate Rice, Director of Product Management speaks to Risk & Insurance.
Mar 2024

FDA Evaluates Report of Suicidal Thoughts with GLP-1 Receptor Agonist

While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.
Feb 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

JAMA Study Questions the Effectiveness of Negative Pressure Wound Therapy

In a randomized clinical trial of 460 patients, researchers found the treatment to have similar impact on self-rated disability as standard wound dressing.
Jul 2018

IQVIA Reports on Global Oncology Trends

Global spending on cancer therapies now exceeds $133 billion.
Jun 2018

The Craze Over Kratom

Kratom continues to grow in popularity as a drug for pain and opioid withdrawal, despite concerns from the FDA, CDC and DEA.
May 2018
1 22 23 24 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle